feed,title,long_url,short_url
Benzinga,"The Daily Biotech Pulse: Eloxx Resumes Cystic Fibrosis Study, Rexahn's Reverse Merger, Ultragenyx, Epizyme Await FDA Decisions",https://www.benzinga.com/general/biotech/20/06/16297177/the-daily-biotech-pulse-eloxx-resumes-cystic-fibrosis-study-rexahns-reverse-merger-ultragenyx-epi,https://j.mp/2CjXoKi
